Medical & Clinical Disclaimer

Inside Peptides explains peptide research and its limits. It is not medical advice: personal health decisions belong with a qualified professional.

Page updated Inside Peptides Editorial TeamEducational reference
Read before using this information

Educational information cannot assess your personal medical needs. In an emergency, contact local emergency services immediately.

01 / Medical & Safety Notice

Education, not individual medical care

Inside Peptides publishes educational information about peptide biology, clinical studies, safety, and regulatory context. This includes our monographs, comparisons, illustrations, evidence grades, and research updates.

Information does not replace a clinical assessment.

Our content is not personal medical advice, diagnosis, treatment, or a prescription. Reading the website or contacting our editorial team does not establish a clinician–patient relationship.

Never disregard professional medical advice or delay seeking care because of something you read here.

02 / Medical & Safety Notice

Personal treatment decisions require clinical advice

A qualified healthcare professional can consider your medical history, current medicines, allergies, health conditions, and treatment goals. Those factors cannot be assessed through a general research article.

  • Do not start, stop, substitute, or change a prescribed treatment based solely on this website.
  • Study doses, routes, and schedules describe research methods; they are not instructions for self-treatment.
  • For questions about interactions, side effects, pregnancy, breastfeeding, or use in children, consult your clinician or pharmacist.
03 / Medical & Safety Notice

Research findings have limits

A biological mechanism, laboratory result, or animal study does not establish clinical benefit in people. Small or preliminary human studies may leave important questions about effectiveness, adverse effects, and long-term outcomes unanswered.

Our evidence grades summarize an editorial assessment of a particular claim. They do not guarantee a treatment outcome or certify a product as safe. A lack of reported adverse events is not proof that a substance has no risks.

Read the study population, limitations, sources, and review status alongside each conclusion. See our evidence methodology and medical review policy.

04 / Medical & Safety Notice

Approval applies to a specific product and use

FDA approval concerns a particular medicine and its labeled indications. It does not establish that every product containing the same peptide, every formulation, or every proposed use has been evaluated or approved. Regulatory status also varies by jurisdiction and can change.

Off-label prescribing of an approved medicine is different from using an unapproved substance. A healthcare professional may prescribe an approved medicine for an unapproved use, but the FDA has not determined safety and effectiveness for that specific use. Read the FDA’s explanation of off-label use.

Compounded drugs are not FDA-approved; the FDA does not review their safety, effectiveness, or quality before marketing. Compounding can serve specific medical needs, but it does not make a compounded product equivalent to an approved medicine. See FDA information on compounding.

05 / Medical & Safety Notice

Unapproved products and research-use labels

Discussion of an experimental peptide is not an endorsement of its purchase or use. “Research use only” labels, vendor claims, purity percentages, and certificates of analysis do not establish that a product is suitable for human treatment.

Unapproved products may have unresolved questions about identity, strength, impurities, sterility, and effects in people. Risks are substance- and product-specific. For example, the FDA identifies potential immunogenicity and peptide-impurity concerns for BPC-157 and notes limited safety information; this should not be presented as proof of every possible harm.

Consult the FDA’s specific bulk-substance safety concerns and our safety guides. We do not provide sourcing, injection, reconstitution, or personalized dosing instructions.

06 / Medical & Safety Notice

Medical emergencies and suspected adverse effects

For a suspected emergency, seek immediate care.

Contact your local emergency services or go to an emergency department. Do not wait for a reply from Inside Peptides or use this site to assess an urgent situation.

For a suspected medicine-related adverse effect that is not an emergency, contact a healthcare professional promptly. They can advise on assessment, treatment, and reporting to the appropriate regulator.

07 / Medical & Safety Notice

Publication limits and corrections

We aim to reflect the available evidence accurately, but a published page may contain errors or may not yet include a new study, label change, or regulatory decision. An update date does not mean every statement received independent medical review.

Check the original sources and current official product information with your healthcare professional. This website is also not legal advice or a determination of a product’s legality in your location.

To flag a factual error, use our editorial contact page and include the page URL and supporting source. Please do not send sensitive personal medical information. Our team cannot assess symptoms or answer individual treatment requests. Read our corrections policy.